Brought to you by Nuclear Education Online (NEO)                    Volume 2, No. 4               May 2004

2004 BPS Exam Scheduled
The Board of Pharmaceutical Specialties will administer the BCNP exam on Saturday, October 2, 2004 at 20 sites across the U.S. (additional sites may be requested).  BPS certification is considered to be at the advanced practice specialty level and there are specific education and experience criteria that a candidate must meet before sitting for the exam.  There are currently 468 board certified nuclear pharmacists in the U.S.  If you would like to join the ranks, your application is due by August 1, 2004.  For more information contact BPS at
USP Chapter <797>
On January 1, 2004, USP Chapter <797> Pharmaceutical Compounding: Sterile Preparations came into effect.  This chapter details the procedures and requirements for compounding sterile preparations (including radiopharmaceuticals) and sets standards that are applicable to all practice settings.  These standards may be adopted and enforced by state boards of pharmacy.  You can obtain copy of Chapter <797> from for $25.  The ASHP has published a summary document available online.  As you can imagine, there are several conflicts between compounding guidelines and radiation safety.  Please submit comments to APhA Nuclear Section Chair-Elect Steve Dragotakes at by May 31.  The USP Expert Panel will be reconvening in July or August for possible revisions.

NeoRx Signs Agreement with Cardinal to Distribute Ho-166 STR

May 17, NeoRx signed an agreement with Cardinal Health to dispense and distribute Holmium-166 DOTMP for Skeletal Targeted Radiotherapy (STR) in multiple myeloma patients.  This will facilitate additional clinical sites in the Phase III study of this radiopharmaceutical.  See the NeoRx press release for more information...

Photos from APhA Meeting

As promised, we have included a few pictures from the APhA meeting in Seattle.  We hope to see you in Orlando in March 2005!  View pictures..

FIP Meeting Includes Nuclear Programs

The International Pharmaceutical Federation (FIP) meeting comes to America this year.  New Orleans will host the meeting Sept. 4-9, 2004.  There are several nuclear sessions for you to attend.  For more information...
Comments or Suggestions?  Let us know your thoughts about the newsletter.

June 19-23 SNM 51st Annual Meeting,   Philadelphia, PA
Aug. 1 BCNP Exam Registration Deadline
Sept. 4-9 FIP Annual Meeting, New Orleans, LA
Sept. 4-8 European Nuclear Medicine Meeting, Helsinki, Finland
Sept. 9-12 Third Annual Meeting of the Society for Molecular Imaging
St. Louis, Missouri
Sept. 10-12 Southeastern Chapter Meeting
Clearwater Beach, Florida
Sept. 30-Oct 2 ASNC Annual Meeting, Clearwater, FL

 If this email does not view graphics properly go to

To subscribe to this mailing list click here.

Optically Stimulated Luminescence (OSL) Dosimeters have been introduced in the last few years.  This process utilizes a laser beam (light photons) to stimulate emission of photons from crystal imperfections.  OSL dosimeters have several advantages:

   Sensitivity ~ 1 mrem
      (vs. ~30 mrem for TLD)

   Multiple reads can be performed

OSL differs from TLD in that trapped charges are released to combine with luminescence centers using optical energy rather than thermal energy. The optical energy required to generate luminescence is very low and only a small fraction of the trapped charge is released. Therefore, an irradiated OSL dosimeter can be repeatedly stimulated to provide multiple dose evaluations for improved precision or confirmation of an earlier analysis.

A 60 year old woman with a history of coronary artery disease (CABG x2),  diabetes, and lower left leg amputation  fell and injured her right hip.  The ambulance arrived but the woman refused to be transported by ambulance and rode her scooter to the nearby hospital with the ambulance following behind....  Continued....

Brought to you by

2004 Nuclear Education Online
4301 W. Markham #522
Little Rock, AR  72205
For more information, contact Nicki Hilliard